GBA1 and Parkinson disease: People with PD carrying GBA1 variants, especially pathogenic severe variants such as p.L483P (more commonly known as L444P), display a more severe clinical phenotype, characterised by a higher burden of autonomic symptoms and olfactory dysfunction (Carandina et al., 2022; Menozzi and Schapira, 2021).